Predicting Outcomes in Critically Ill Brain Patients Receiving Tube Feeding
Studies a prediction model using blood markers in adults with acute stroke or brain infection.
Plain-language title generated from the registry record
Registry title: Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients
Key facts
- Where
- Beijing, Chifeng, Guiyang, Hohhot, Jilin City, Jinan, Kunming, Lanzhou, Liaocheng, Shijiazhuang, Suzhou, Taiyuan, Tangshan, Yinchuan, and Zunyi, ChinaSee the 19 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT06849011, who can take part
Where in China
- Beijing Hui People's HospitalBeijing, ChinaNo longer taking part
- The Ninth Medical Center of Chinese PLA General HospitalBeijing, ChinaNo longer taking part
- Xuanwu Hospital, Capital Medical UniversityBeijing, ChinaNo longer taking part
- You'anmen HospitalBeijing, ChinaNo longer taking part
- Chifeng Municipal HospitalChifeng, ChinaNo longer taking part
- Guizhou Provincial People's HospitalGuiyang, ChinaNo longer taking part
- Inner Mongolia Autonomous Region People's HospitalHohhot, ChinaNo longer taking part
- The First Hospital of Jilin UniversityJilin City, ChinaNo longer taking part
- Qilu Hospital of Shandong UniversityJinan, ChinaNo longer taking part
- The 960th Hospital of Joint Logistics Support Force of Chinese PLAJinan, ChinaNo longer taking part
- The First People's Hospital of Yunnan ProvinceKunming, ChinaNo longer taking part
- The 940th Hospital of Joint Logistics Support Force of Chinese PLALanzhou, ChinaNo longer taking part
- Liaocheng People's HospitalLiaocheng, ChinaNo longer taking part
- The First Hospital of Hebei Medical UniversityShijiazhuang, ChinaNo longer taking part
- The Second Affiliated Hospital of Suzhou UniversitySuzhou, ChinaNo longer taking part
- The Second Hospital of Shanxi Medical UniversityTaiyuan, ChinaNo longer taking part
- Tangshan People's HospitalTangshan, ChinaNo longer taking part
- General Hospital of Ningxia Medical UniversityYinchuan, ChinaNo longer taking part
- Affiliated Hospital of Zunyi Medical UniversityZunyi, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Yan Zhang
- Trial code
- NCT06849011
- Record updated
- 27 February 2025
- Original description
The study aims to develop and validate a prognostic prediction model for adverse outcomes in neurocritical patients receiving enteral nutrition based on key inflammatory and metabolic markers. This model will serve as a clinical tool to help physicians identify high-risk patients and guide individualized nutritional support strategies.Read full original descriptionShow less
Development and Validation of a Prognostic Prediction Model for Adverse Outcomes in Neurocritical Patients Receiving Enteral Nutrition Based on Key Inflammatory and Metabolic Markers
The study aims to develop and validate a prognostic prediction model for adverse outcomes in neurocritical patients receiving enteral nutrition based on key inflammatory and metabolic markers. This model will serve as a clinical tool to help physicians identify high-risk patients and guide individualized nutritional support strategies.
Inclusion: Age between 18 and 80 years, no gender restrictions; Within 7 days of disease onset and expected NICU stay of at least 7 days; Eligible for enrollment within 24 hours of NICU admission, with enteral nutrition (EN) initiated and continued for at least 7 days; Non-traumatic severe brain injury patients (including cerebrovascular disease and encephalitis) with a Glasgow Coma Scale (GCS) score ≤12; NRS 2002 score ≥3; Kuwata drinking test ≥ grade 3; Acute Gastrointestinal Injury (AGI) grade 1 or 2; Signed informed consent obtained from the patient or their legal representative.
Exclusion: Severe malnutrition prior to admission, defined as BMI < 16 kg/m²; Receiving hypothermia treatment or core body temperature < 36°C; End-stage disease with an expected survival time of < 48 hours, or severe dysfunction of the heart, lungs, or other vital organs, leading to hemodynamic instability; Malignant tumors; Pregnant or lactating women.